Breast Cancer Drug Raises Blood Clot Risk, Should Have 'Black Box' Warning, JAMA Stud

[News]

Genentech's cancer drug Avastin -- which FDA approved in February for treatment of advanced breast cancer -- increases a patient's risk of developing blood clots in veins, a condition known as venous thromboembolism, or VTE, according to a

More... (http://www.medicalnewstoday.com/articles/130130.php)